McKesson Ventures has returned to back a $40m round for Lightship, having co-led a $20m series B last year.

US-based clinical trial services provider Lightship obtained $40m in a funding round on Wednesday that included McKesson Ventures, the corporate venture capital unit of pharmaceuticals distributor McKesson.

Define Ventures and private investor Brook Byers co-led the round, while Khosla Ventures and Time Ventures also took part.

Founded in 2018, Lightship operates an end-to-end service to run decentralised clinical research trials at scale. The fresh financing will allow Lightship to expand domestically and internationally, with a new office set to be…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn